According to research, presented on July 28 at the 2015 American Association for Clinical Chemistry (AACC) Annual Meeting & Clinical Expo in Atlanta, US, hair samples can be used to measure the effects of asthma on the cortisol levels of women during pregnancy.

The research shows that cortisol tend to be lower among pregnant women with asthma than among pregnant women without the chronic, inflammatory lung disease – the findings that suggest that hair samples may provide scientists with a simple tool for determining if and how cortisol is linked to poorer pregnancy outcomes.

“We hope hair samples will help establish the role that changes in cortisol levels throughout pregnancy have on the health of women and their children,” said study co-author Laura Smy, a PhD student at the University of Toronto.

While currently researchers ask pregnant women for frequent blood or saliva samples to track their cortisol levels, these results are difficult to interpret as cortisol fluctuates during the day and current methodology reflects only one point in time. Hair, on the other hand, stores cortisol levels over a long period of time with one centimetre showing cortisol levels during a particular month.

To investigate whether hair samples could be used to assess the effects of asthma on cortisol levels during pregnancy, a research team led by Gideon Koren, MD, a clinical pharmacologist at the University of Toronto, and Bruce Carleton, PharmD, at the University of British Columbia, collected hair samples from 93 pregnant women, of whom 62 had asthma and 31 did not. About half of the women with asthma were being treated with inhaled corticosteroids.

“For both the control and the asthma groups we could see a rise in cortisol over the course of the pregnancy and then a decline during the post-partum period,” said Smy. “”For the individuals with asthma, whether or not they were using inhaled corticosteroids, their response to the cortisol increase was dampened. They had significantly lower hair-cortisol levels during both their second and third trimesters than the women in the control group.”

According to Smy, the dampened response to cortisol observed in the current study may be due to “adrenal fatigue”—prolonged exposure to high cortisol levels that eventually causes the adrenal glands to significantly reduce their output of the hormone. Future research will be needed, she added, to both confirm this study’s findings and to determine the role that changes in cortisol during pregnancy may have on pregnancy outcomes and fetal wellbeing.

Both Studies Show Consumer Confusion on Added Sugars Labeling

 

On July24, the US Food and Drug Administration (FDA) announced an update to its proposal to revise the Nutrition Facts Panel (NFP). The proposal now includes a per cent DV for added sugars.

While designing and commissioning independent research, IFIC Foundation used FDA protocols to inform its survey, specifically, the nutrition profiles of labels and product types shown to consumers to test their understanding of these labels. One of the main concerns of the added sugars labelling discussion is understanding how labeling “Added Sugars” might affect the consumer’s ability to correctly identify the total amount of sugars in a product.

“A key question to answer in our consumer research is whether or not an “Added Sugars” declaration on the NFP provides clear information that is well understood by consumers that would be used appropriately in efforts to make informed dietary choices,” said co-author Kris Sollid, RD, IFIC Director of Nutrients Communications. “The short (and sweet) answer…providing added sugars information significantly decreases the ability for consumers to accurately identify the total amount of sugars in a product.”

According to the data, 92 per cent of consumers were able to identify the total amount of sugars in a product where “Sugars” are listed and “Added Sugars” are not. When viewing labels with added sugars information in FDA’s proposed format, 55 per cent were correct.

The FDA’s study has also shown that respondents were more accurate in identifying the grams of sugars per serving using the current label compared to the proposed label (81 per cent vs. 65 per cent). They also found respondents were more accurate in identifying the grams of sugars per container using the current label compared to the proposed label (54% vs. 36%).

IFIC Foundation research findings are published online as an Article in Press by the Journal of the Academy of Nutrition and Dietetics.

On July 27, Rona Ambrose, minister of health, announced $4.5 million dollar investment in a new national network focused on improving the health of Canadians living with hepatitis C and preventing new infections. The announcement was made in advance of World Hepatitis Day on July 28.

“Our Government is committed to working with provinces, territories and other partners to address the challenge of hepatitis C in Canada,” Ambrose says. “This network will be an important resource as we work together to raise awareness, prevent new infections, and improve the health of Canadians living with hepatitis C.”

In 2010, the World Health Organization along with the World Hepatitis Alliance made World Hepatitis Day one of only four official disease-specific health days. Celebrated annually on July 28, the initiative raises awareness about viral hepatitis.

The National Collaborative Hepatitis C Networkwill be led by Dr. Naglaa Shoukry, a scientist at the Centre Hospitalier de l’Université de Montréal Research Centre (CRCHUM) and an Associate Professor at Université de Montréal, and involve more than 60 researchers, health professionals and partners across the country. Through the network, funded through a partnership between the Canadian Institutes of Health Research and the Public Health Agency of Canada, Dr. Shoukry and her team will work to improve prevention strategies, enhance access and adherence to treatment and better understand the health challenges of Canadians living with hepatitis C.

“Our network is guided by the overall goal of eliminating hepatitis C in Canada,” says Dr. Shoukry. “Through a continuous pipeline from discovery to implementation, we intend to reduce transmission of the virus through novel prevention strategies and vaccine development, increase the number of those cured of infection in particular in vulnerable populations through innovative treatment strategies and cascade of care, and improve health outcomes among those living with hepatitis C.”